IFNB1 and cancer: Our results provide clear evidence that TPF downregulates key antiviral and pro-inflammatory genes, including IFN-β, MX2, and IL6 (Figure 4A), thereby enhancing the susceptibility of cancer cells to VSVΔ51 infection.